StockHealthcare · Biotechnology

$EVMN

Evommune, Inc.

Price · $EVMNvia TradingView

AI sentiment · 7d0 articles

No enriched coverage for $EVMN in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $EVMN in the last 30 days.

Evommune (NYSE:EVMN) Stock Price Down 7.6% - Should You Sell?

Shares of Evommune (NYSE:EVMN) fell 7.6% on Tuesday, trading at approximately $21.67 with significantly reduced volume. The clinical-stage biotech company, focused on chronic inflammatory diseases, missed its last earnings target and has a negative P/E ratio. Despite a consensus "Buy" rating from analysts with an average price target of $47.17, one firm, Weiss Ratings, issued a "sell" rating.

MAR 6·MarketBeat

Evommune (NYSE:EVMN) Trading 6.9% Higher - Time to Buy?

Evommune (NYSE:EVMN) shares traded 6.9% higher on Friday at $26.81, although with sharply below-average trading volume. The company holds a "Moderate Buy" rating from analysts with an average price target of $49.67, despite mixed fundamentals including a negative P/E and a recent earnings miss. Several institutional investors initiated significant positions in Q4 2025.

via TradingView

News on $EVMN

All news →